138 related articles for article (PubMed ID: 11411896)
21. Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells.
Maestrelli F; Zerrouk N; Chemtob C; Mura P
Int J Pharm; 2004 Mar; 271(1-2):257-67. PubMed ID: 15129993
[TBL] [Abstract][Full Text] [Related]
22. Preparation and physicochemical characterization of naproxen-PLGA nanoparticles.
Javadzadeh Y; Ahadi F; Davaran S; Mohammadi G; Sabzevari A; Adibkia K
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):498-502. PubMed ID: 20719477
[TBL] [Abstract][Full Text] [Related]
23. Characterization of naproxen-loaded solid SMEDDSs prepared by spray drying: the effect of the polysaccharide carrier and naproxen concentration.
Čerpnjak K; Zvonar A; Vrečer F; Gašperlin M
Int J Pharm; 2015 May; 485(1-2):215-28. PubMed ID: 25772420
[TBL] [Abstract][Full Text] [Related]
24. Enhanced dissolution and bioavailability of raloxifene hydrochloride by co-grinding with different superdisintegrants.
Jagadish B; Yelchuri R; K B; Tangi H; Maroju S; Rao VU
Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):293-300. PubMed ID: 20190431
[TBL] [Abstract][Full Text] [Related]
25. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
[TBL] [Abstract][Full Text] [Related]
26. Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique.
Nokhodchi A; Maghsoodi M
AAPS PharmSciTech; 2008; 9(1):54-9. PubMed ID: 18446461
[TBL] [Abstract][Full Text] [Related]
27. Physical characterization of naproxen sodium hydrate and anhydrate forms.
Di Martino P; Barthélémy C; Palmieri GF; Martelli S
Eur J Pharm Sci; 2001 Dec; 14(4):293-300. PubMed ID: 11684403
[TBL] [Abstract][Full Text] [Related]
28. Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique.
Maghsoodi M; Hassan-Zadeh D; Barzegar-Jalali M; Nokhodchi A; Martin G
Drug Dev Ind Pharm; 2007 Nov; 33(11):1216-24. PubMed ID: 18058318
[TBL] [Abstract][Full Text] [Related]
29. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
Paudel A; Loyson Y; Van den Mooter G
J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
[TBL] [Abstract][Full Text] [Related]
30. Mung bean (Vigna radiata) porous starch for solubility and dissolution enhancement of poorly soluble drug by solid dispersion.
Nadaf S; Jadhav A; Killedar S
Int J Biol Macromol; 2021 Jan; 167():345-357. PubMed ID: 33253744
[TBL] [Abstract][Full Text] [Related]
31. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
32. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
33. Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization.
Adibkia K; Javadzadeh Y; Dastmalchi S; Mohammadi G; Niri FK; Alaei-Beirami M
Colloids Surf B Biointerfaces; 2011 Mar; 83(1):155-9. PubMed ID: 21130612
[TBL] [Abstract][Full Text] [Related]
34. Does the molecular mobility and flexibility of the saccharide ring affect the glass-forming ability of naproxen in binary mixtures?
Minecka A; Kamińska E; Tarnacka M; Jurkiewicz K; Talik A; Wolnica K; Dulski M; Kasprzycka A; Spychalska P; Garbacz G; Kamiński K; Paluch M
Eur J Pharm Sci; 2020 Jan; 141():105091. PubMed ID: 31655208
[TBL] [Abstract][Full Text] [Related]
35. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions.
Kumar S; Burgess DJ
Int J Pharm; 2014 May; 466(1-2):223-32. PubMed ID: 24614581
[TBL] [Abstract][Full Text] [Related]
36. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
Maghsoodi M; Esfahani M
Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
[TBL] [Abstract][Full Text] [Related]
37. Zinc-naproxen complex: synthesis, physicochemical and biological evaluation.
Sharma J; Singla AK; Dhawan S
Int J Pharm; 2003 Jul; 260(2):217-27. PubMed ID: 12842341
[TBL] [Abstract][Full Text] [Related]
38. Nanocomposites of 2-arylpropionic acid drugs based on Mg-Al layered double hydroxide for dissolution enhancement.
Berber MR; Minagawa K; Katoh M; Mori T; Tanaka M
Eur J Pharm Sci; 2008 Nov; 35(4):354-60. PubMed ID: 18789388
[TBL] [Abstract][Full Text] [Related]
39. Nanosizing drug particles in supercritical fluid processing.
Pathak P; Meziani MJ; Desai T; Sun YP
J Am Chem Soc; 2004 Sep; 126(35):10842-3. PubMed ID: 15339159
[TBL] [Abstract][Full Text] [Related]
40. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
